openPR Logo
Press release

Science News: CAR T Cell Therapy Market Brief Analysis By Top Key Players - Kite Pharma, Inc., Juno Therapeutics, Pfizer, Inc. Celgene Corporation, Cellectis, Sorrento Therapeutics, Bluebird bio, and Immune Therapeutics

10-26-2018 06:28 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

CAR T Cell Therapy Market Size, CAR T Cell Therapy Market Share, CAR T Cell Therapy Market Trends

CAR T Cell Therapy Market Size, CAR T Cell Therapy Market Share, CAR T Cell Therapy Market Trends

According to the new market research “CAR T Cell Therapy Market [By Target Antigen (CD19, CD20, MESO, HER2, EGFRV III, and Others); By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, and Others); and By Regions]: Market size & Forecast, 2018 – 2025", The CAR T Cell Therapy market is expected to reach USD 2.99 Billion by 2025 from USD 149.3 Million in 2017, at a CAGR of 45.6%.

Request for Free Sample Report @ https://www.polarismarketresearch.com/industry-analysis/CAR-T-Cell-Therapy-Market/request-for-free-sample

The CAR T therapy uses the patient’s own immune system as well as develops it to target the tumor cells and execute them. This therapy is depending on the re-engineering of T-cells to make them recognize cancer cells and target such cells when they generally fail to do so. This therapy has proven very operative in patients with blood cancer who have already gone through alternative therapies such as chemotherapy.

Top Key Player:-

Novartis International AG
Kite Pharma, Inc.
Juno Therapeutics
Pfizer, Inc. Celgene Corporation
Cellectis
Sorrento Therapeutics
Bluebird bio
Immune Therapeutics.

The Choice of the Target Antigen to Define the Type of Therapy
The CD19 antigen present on the surface of the B cell has proven to be the highly effective CAR T cell therapy with approved treatment for leukemia and lymphoma where B cells have become carcinogenic. Currently, Kymriah by Novartis and Yescarta (manufactured and distributed by Kite Pharma, a subsidiary of a US-based company, Gilead Sciences) are only approved products for B Cell Acute Lymphoblastic Leukemia (ALL) and Large B-Cell lymphoma respectively. The key players in this sector are evolving new CAR-T therapies targeting different antigens for solid tumor including L1CAM, MUC16 and for blood cancers including CD123, CD22, BCMA among others.

Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.polarismarketresearch.com/industry-analysis/CAR-T-Cell-Therapy-Market/speak-to-analyst

Global Market Significance

CAR-T is a vastly revolutionary therapy which contains a distinctive business model in the pharmaceutical industry to reach the commercial stage. This therapy signifies a novel methodology with large potential in terms of manufacturing procedure and toxicity management. Leading key market players such as Novartis, Gilead, Celgene, and others are gaining full exposure to the immuno-oncology field with the ongoing merger and acquisition activities, product developments, and clinical trials to increase the importance of cellular therapy.

The Global CAR T Cell Therapy Market is segmented on the basis of the target antigen, application, and geography. On the basis of a target antigen, the global CAR T Cell Therapy Market is segmented into CD19, CD20, MESO, HER2, EGFRV III, and Others. On the basis of application, the global CAR T Cell Therapy Market is segmented into Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, and Others. The first therapy approved was observed among pediatrics and/or young adults Acute Lymphoblastic Leukemia (ALL) – an ailment with a high unmet need where CAR-T indicated high effectiveness. The therapy for Diffuse Large B-Cell Lymphoma (DLBCL) was estimated to be the largest market sharing segment followed by multiple myeloma. In addition, Chronic Lymphocytic Leukemia and follicular lymphoma are expected to be the other major market segments during the forecast period.

Read More For Details: https://www.polarismarketresearch.com/industry-analysis/CAR-T-Cell-Therapy-Market/

In terms of geography, North America region is estimated to dominate the global CAR T Cell Therapy Market. Increasing research and developments programs as well as ongoing regulatory approvals are factors attributed for the augmented market growth of CAR T cell therapy. For instance, Kymriah (a Novartis product) has cleared the USFDA approval in August 2017 for the treatment of patients suffering from acute lymphoblastic leukemia. Moreover, key players such as Novartis and Kite are the first to reach US market and are expected to focus on expansion via the number of academic centers that can provide appropriate cancer treatments in 2018.

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us-

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Science News: CAR T Cell Therapy Market Brief Analysis By Top Key Players - Kite Pharma, Inc., Juno Therapeutics, Pfizer, Inc. Celgene Corporation, Cellectis, Sorrento Therapeutics, Bluebird bio, and Immune Therapeutics here

News-ID: 1332837 • Views: 856

More Releases from Polaris Market Research & Consulting

What's driving the Blockchain Technology Market Trends? Microsoft Corporation, I …
The worldwide market size for blockchain technology is estimated to grow at a CAGR of 41.6% between 2018 and 2026 and is anticipated to reach USD 16.82 billion by 2026. According to a new study published by Polaris Market Research. Also termed as Distributed Ledger Technology (DLT), blockchain enables secure transaction over a distributed network. Since the transactions are taken place usually over the network, it is difficult to reverse
What's driving the Precision Farming Market Trends? Ag Leader Technology, AgJunc …
The global precision farming/agriculture market was valued at 3,833 million in 2017 and is anticipated to reach over USD 13,016 million by 2026 with grow at a CAGR of more than 14.7% during the forecast period According to a new study published by Polaris Market Research. In 2017, the yield monitoring application dominated the global market, in terms of revenue. North America is expected to be the leading contributor to
What are the different trends in Electric Vehicles (EV) Market to boost its grow …
Polaris Market Research has new report published the addition of the “The global Electric Vehicles Market Worth $912 Billion By 2026 | CAGR: 38.4%”, the report classifies the global Electric Vehicles market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth Get PDF Sample of “Electric Vehicles Market”: https://www.polarismarketresearch.com/industry-analysis/electric-vehicles-ev-market/request-for-sample The global electric vehicles market is anticipated to
What are the different trends in Third Party Logistics Market to boost its growt …
Polaris Market Research has new report published the addition of the “The global third-party logistics market is anticipated to reach USD 1,337.91 billion by 2026”, the report classifies the global third-party logistics market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth according to a new report The report “Third Party Logistics (3PL) Market Share, Size,

All 5 Releases


More Releases for CAR

Car Monitor Display
https://www.qandqmarketresearch.com/reports/7152010/car-monitor-display-market-78 Global Car Monitor Display Market Insights, Forecast to 2025 This report presents the worldwide Car Monitor Display market size value, production and consumption, splits the breakdown data status 20132018 and forecast to 2025, by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis. Download Free PDF Sample
Sports Car Industry Forecasts
Albany, New York, November 8, 2016: Market Research Hub has announced a new research report to its database, titled “Sports Car industry forecasts”. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far
India Car Rental Market
A research study, titled “India Car Rental Market: Trends, Opportunities And Forecasts (2016-2021)” - (By Value, By Region, By Segment - Radio Taxi, Corporate Rental, Aggregators and Affilators; Key Players; Market Share And Dynamics),” has been recently added by MarketResearchReports.biz to its huge repository of research studies. The research study further provides a detailed analysis of the car rental market in India, focusing on the product segmentation, competitive scenario, and
Apple Car
Apple Car – The new Apple driverless car was unveiled it is said to be the top hybrid electric car. The Apple Car will change the automotive industry very soon, learn why, & discover what the Apple Driverless Car will contain. Apple Car - All over, an auto appears like a heartbreaking thing for Apple Inc. to manufacture. Autos are a fiercely commoditised, staggeringly costly, for the most part low-edge
Connected World - Connected Car
According to ABI research, the number of global users of telematics smartphone applications is set to explode in the next five years from 3.2 million to 129 million users. It is vital that automotive manufacturers keep up-to-date with developments in this field if they are to remain competitive in this fast-paced market. Because their customers won’t wait. At IQPC’s 4th International Conference Connected Vehicles from 12-14 April in Berlin, experts
Car insurance: Over 50 car insurance advantages
Over 50 car insurance It has been observed that older drivers tend to have a more mature approach towards driving than new drivers. Car insurance companies are more and more eager to target drivers aged 50 plus or those that have retired as older drivers are more experience, fewer accidents and more consistent. We can say older drivers are present less of a risk. This means the over 50s are less